Terkko Navigator / lihao/ Feeds

Timo Kaukosesta tulee uusi piiriylilääkäri

Voiko aivoja opettaa pitämään liikunnasta?

Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease

Measuring Similarity among Protein Sequences Using a New Descriptor

Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells

Subchronic Study of a White Kidney Bean (Phaseolus vulgaris) Extract with α-Amylase Inhibitory Activity

Kannattaako näihin kansanosakkeisiin tarttua nyt? – Moni on kärsinyt tuntuviakin tappioita

Laatunen Postin työriidasta: Eskaloitunut tavattoman suureksi – ”Kuitenkin tämä jumittava kysymys koskee aika pientä porukkaa”

Medicinal Foods

Unraveling the Inhibition of Intestinal Glucose Transport by Dietary Phenolics: A Review

Mexican Traditional Plant-Foods: Polyphenols Bioavailability, Gut Microbiota Metabolism and Impact Human Health

Nopal (Opuntia spp.) and its Effects on Metabolic Syndrome: New Insights for the Use of a Millenary Plant

In vitro Gastrointestinal Models for Prebiotic Carbohydrates: A Critical Review

Effects of Polyphenol-Rich Fruit Extracts on Diet-Induced Obesity in Rodents: Systematic Review and Meta-Analysis

Cancers, Vol. 11, Pages 1845: Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma

Showing their mettle: extraradical mycelia of arbuscular mycorrhizae form a metal filter to improve host Al tolerance and P nutrition

In This Issue/Research Watch/News-in-Brief/News from 002the IASLC Tobacco Control Committee.

Sequence, Treat, Repeat: Addressing Resistance in EGFR-Mutant NSCLC.

SCLC, Paraneoplastic Syndromes, and the Immune System.

Mutations in the Antioxidant KEAP1/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments.

Lung Cancer in the Middle East and North Africa Region.

Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up.

Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer.

Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.

Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.

Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts.

Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.

Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.

Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.

A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib.

Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.

EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples.

Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.

Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden.

Giant Secondary Overgrowth of Type-1 Pulmonary Cystic Airway Malformation Upon Development of Anaplastic Lymphoma Kinase-Rearranged Adenocarcinoma.

Erratum.

Erratum.

Erratum.

Erratum.

Erratum.

Early Onset Pulmonary Toxicity With Lorlatinib in a Patient With Previous Pulmonary Toxicity From Brigatinib.

The Relative Impact of Family History of Different Cancers on Lung Cancer Risk.

RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome.

Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion.

Thoracic Endometriosis With Catamenial Hemoptysis and Hemothorax: Long-Term Follow-Up After GnRH-a Treatment.

A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib.

In Response to the Letter by Dr. Yang et al, Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Forcing on Organ-Specific irAEs and the Critical Role of Steroids.

Response to Letter to the Editor.

Editorial introductions.

Editorial: Merging therapeutics and supportive care: synergy and yield.